During this critical moment in global healthcare, the show must go on for the largest and longest-running life sciences industry event— just virtually!
IQVIA is pleased to be a leading sponsor of 2020 DIA Global Annual Meeting this week, where our experts will be leading a variety of discussions to help the industry tackle complex challenges and brainstorm ways to continue bringing much-needed therapies to patients regardless of potential roadblocks.
During this first full day of programming, several IQVIA leaders articulated actionable insights to help clinical trial sponsors and the broader industry continue studying disease and driving innovation during the COVID-19 crisis and beyond.
Here’s a brief recap of their Innovation Theater presentations, which are available to DIA conference registrants to view on demand for the next 60 days.
- During “COVID-19 Disruption Provides a Pivotal Opportunity to Accelerate Patient Engagement Innovation,” Erica Prowisor, global head, Recruitment and Retention for IQVIA Research and Development Solutions, discussed IQVIA’s strategies for maintaining trial continuity in a complicated new era of clinical research. Recognizing this time in history as a unique opportunity to accelerate patient-centric innovation, Prowisor discussed how IQVIA is laser-focused on mobilizing its wide breadth of data, technology, analytics and expertise to unite all stakeholders (e.g., sponsors, site teams, and patients) and rethink how to deliver more agile recruitment strategies. Through IQVIA’s Direct-to-Patient Recruitment solution, the team is using an innovative, holistic digital approach, to drive productivity to safely identify, recruit and retain the right patients for each trial while reducing the burden on site and study teams.
- More than ever, patients want know about their treatment and should be treated as valued partners in clinical development. In the “Digital Patient Experience/Virtual Trials” presentation, IQVIA’s MaryAnne Rizk, senior vice president, Research and Development Solutions Digital Strategy, and Jean Paty, vice president, Patient Centered Sciences, spoke about the importance of creating a patient-centric experience from molecule to market for all stakeholders. Today, IQVIA offers a new SaaS-based cloud platform called Orchestrated Clinical Trials to produce an uninterrupted flow of data-driven evidence to quickly close the gap between data collection and decision-making and allow study teams and sponsors to better understand and respond to patient needs.